In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer

Retinol molecule was modified to predict the inhibitors of telomerase reverse transcriptase for the treatment of arsenical cancer through in silico study. Telomerase activity is expressed in the cancerous conditions which can be the target for anticancer activity by inhibiting telomerase reverse tra...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kipchu Tshering, Mir Misbahuddin
Materialtyp: Artigo
Språk:Inglês
Publicerad: Bangabandhu Sheikh Mujib Medical University 2016-09-01
Serie:Bangabandhu Sheikh Mujib Medical University Journal
Ämnen:
Arsenic
Cancer
In silico
Molecular docking
Retinol
Telomerase reverse transcriptase
Länkar:https://www.banglajol.info/index.php/BSMMUJ/article/view/29650
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk